IgVH Mutation Detection Screening in UAE | 1500 AED | DHA Licensed Lab

Executive Summary & Core Metrics

Diagnostic Accuracy: 99.9% clinical sensitivity achieved through ISO 9001:2015 accredited laboratory protocols (Cert: INT/EGQ/2509DA/3139).

Premium Logistics: VIP mobile phlebotomy with temperature-controlled cold-chain transport, available daily from 8 AM to 11 PM.

Clinical Support: Physicians review every result; a post-test teleconsultation is included to explain findings and guide next steps.

Insurance Assistance: Direct billing and coverage verification via WhatsApp at +971 54 548 8731.

Test Overview & Methodology

The IgVH Mutation Detection Screening test determines the somatic hypermutation status of the immunoglobulin heavy chain variable region gene in B-cell chronic lymphocytic leukemia (CLL). Mutated IGHV status correlates with indolent disease and favorable prognosis, whereas unmutated status indicates aggressive disease requiring early therapeutic intervention. This molecular assay employs PCR amplification followed by Sanger sequencing to precisely characterize the mutational profile of the VH region.

Parameter	Our IgVH Mutation Test	Flow Cytometry (Alternative)
Mutation Status Detection	Yes (somatic hypermutation analysis)	No
Methodology	PCR amplification + Sanger Sequencing	Immunophenotyping by flow cytometry
Clinical Utility	CLL prognosis, therapy selection (IGHV mutational status)	Surface marker identification, minimal residual disease
Turnaround Time	4 working days (Mon sample by 9 AM → Fri report)	1–2 days
Price	1500 AED	~800 AED

Physician Insight & Safety Protocols

“As a specialist in diagnostic radiology with a focus on oncological correlation, I recognize that the IgVH mutation status is a critical pillar in CLL risk stratification. This molecular data must be interpreted alongside clinical examination, imaging findings, and complete blood counts to guide decisions on watchful waiting versus active therapy. Patients should always discuss their results with their treating hematologist before making any treatment changes.”

— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011

Safety Advisory

⚠️ Do not discontinue prescribed medication without consulting your doctor. This test provides prognostic information only and is not a standalone basis for altering therapy.

Exclusion Criteria & Emergency Indicators

Exclusion Criteria

Age restriction: Individuals below 18 years of age without legal guardian consent.
Active infection: Fever ≥ 38.5°C at time of collection may compromise sample integrity.
Recent chemotherapy: Cytotoxic therapy within 2 weeks prior to collection may interfere with assay accuracy.

🆘 Seek Immediate Medical Attention if You Experience

Sudden unexplained bruising or bleeding.
Severe fatigue with pallor and shortness of breath.
Fever above 38.5°C with chills.
Rapidly enlarging lymph nodes with breathing difficulty.

Patient FAQ & Clinical Guidance

1. What does IgVH mutation testing reveal about CLL prognosis?

Detection of somatic hypermutation in the IgVH gene identifies patients with indolent chronic lymphocytic leukemia who have a favorable prognosis and may not need immediate therapy. Mutated IGHV status is associated with slower disease progression and longer overall survival, while unmutated status signals a more aggressive course requiring closer monitoring and earlier intervention.

2. How soon can I get my IgVH mutation test results in the UAE?

With Monday sample receipt by 9 AM, our ISO-accredited lab delivers IgVH mutation results by Friday afternoon. The test requires 4 working days due to the multi-step processing (DNA extraction, PCR, sequencing, and analysis). We offer home collection from 8 AM to 11 PM daily to ensure timely sample transport.

3. Do I need to stop any medications before the test?

No special preparation is required; you can continue all prescribed medications and maintain normal diet before sample collection. Do not discontinue any ongoing treatment without explicit advice from your physician, as this could affect your underlying condition. Only 4 mL of whole blood in an EDTA tube is needed, shipped refrigerated but never frozen.

UAE Regulatory & Data Privacy Adherence

All personal health data is processed in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Our laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139), ensuring global quality standards in every diagnostic step.

Direct Billing & Insurance Verification via WhatsApp: +971 54 548 8731 | Support: +971545488731

Clinical & Logistical Metadata

Test Name	IgVH Mutation Detection Screening
Price (AED)	1500
Turnaround Time	4 working days
Sample Type / Matrix	Whole blood (4 mL in EDTA tube)
Methodology Used	PCR amplification + Sanger Sequencing
ICD-10-CM Code	C91.1
LOINC Code	53541-5
DHA Facility License & Address	License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE